181. Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema.
作者: Cui-Lian Weng.;Yun-Tao Zhao.;Qing-Hua Liu.;Chang-Jun Fu.;Feng Sun.;Yan-Liang Ma.;Yan-Wen Chen.;Quan-Ying He.
来源: Ann Intern Med. 2010年152卷9期590-600页
Noninvasive ventilation (NIV) is commonly used to treat patients with acute cardiogenic pulmonary edema (ACPE), but the findings of a recent large clinical trial suggest that NIV may be less effective for ACPE than previously thought.
182. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.
作者: Suetonia C Palmer.;Sankar D Navaneethan.;Jonathan C Craig.;David W Johnson.;Marcello Tonelli.;Amit X Garg.;Fabio Pellegrini.;Pietro Ravani.;Meg Jardine.;Vlado Perkovic.;Giusi Graziano.;Richard McGee.;Antonio Nicolucci.;Gianni Tognoni.;Giovanni F M Strippoli.
来源: Ann Intern Med. 2010年153卷1期23-33页
Previous meta-analyses suggest that treatment with erythropoiesis-stimulating agents (ESAs) in chronic kidney disease (CKD) increases the risk for death. Additional randomized trials have been recently completed.
183. Meta-analysis: excess mortality after hip fracture among older women and men.
作者: Patrick Haentjens.;Jay Magaziner.;Cathleen S Colón-Emeric.;Dirk Vanderschueren.;Koen Milisen.;Brigitte Velkeniers.;Steven Boonen.
来源: Ann Intern Med. 2010年152卷6期380-90页
Although an increased risk for death after hip fracture is well established, whether this excess mortality persists over time is unclear.
184. Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief.
作者: Harindra C Wijeysundera.;Brahmajee K Nallamothu.;Harlan M Krumholz.;Jack V Tu.;Dennis T Ko.
来源: Ann Intern Med. 2010年152卷6期370-9页
Several meta-analyses have evaluated the efficacy of percutaneous coronary intervention (PCI) compared with medical therapy, but none has focused on angina relief.
185. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events.
Vitamin D and calcium may affect the cardiovascular system independently and interactively.
186. Systematic review: Vitamin D and cardiometabolic outcomes.
作者: Anastassios G Pittas.;Mei Chung.;Thomas Trikalinos.;Joanna Mitri.;Michael Brendel.;Kamal Patel.;Alice H Lichtenstein.;Joseph Lau.;Ethan M Balk.
来源: Ann Intern Med. 2010年152卷5期307-14页
Vitamin D may modify risk for cardiometabolic outcomes (type 2 diabetes, hypertension, or cardiovascular disease).
187. Meta-analysis: effect of interactive communication between collaborating primary care physicians and specialists.
作者: Robbie Foy.;Susanne Hempel.;Lisa Rubenstein.;Marika Suttorp.;Michelle Seelig.;Roberta Shanman.;Paul G Shekelle.
来源: Ann Intern Med. 2010年152卷4期247-58页
Whether collaborative care models that enable interactive communication (timely, 2-way exchange of pertinent clinical information directly between primary care and specialist physicians) improve patient outcomes is uncertain.
188. Meta-analysis: noninvasive coronary angiography using computed tomography versus magnetic resonance imaging.
作者: Georg M Schuetz.;Niki Maria Zacharopoulou.;Peter Schlattmann.;Marc Dewey.
来源: Ann Intern Med. 2010年152卷3期167-77页
Two imaging techniques, multislice computed tomography (CT) and magnetic resonance imaging (MRI), have evolved for noninvasive coronary angiography.
189. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index.
The Revised Cardiac Risk Index (RCRI) is widely used to predict perioperative cardiac complications.
190. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis.
作者: Alexander Tsertsvadze.;Howard A Fink.;Fatemeh Yazdi.;Roderick MacDonald.;Anthony J Bella.;Mohammed T Ansari.;Chantelle Garritty.;Karla Soares-Weiser.;Raymond Daniel.;Margaret Sampson.;Steven Fox.;David Moher.;Timothy J Wilt.
来源: Ann Intern Med. 2009年151卷9期650-61页
Erectile dysfunction (ED) is a common male sexual disorder. The relative benefits and harms of pharmacologic therapies for ED, as well as the value of hormonal testing in men with ED, are uncertain.
191. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.
作者: Sophia Zoungas.;Toshiharu Ninomiya.;Rachel Huxley.;Alan Cass.;Meg Jardine.;Martin Gallagher.;Anushka Patel.;Ali Vasheghani-Farahani.;Gelareh Sadigh.;Vlado Perkovic.
来源: Ann Intern Med. 2009年151卷9期631-8页
Intravenous sodium bicarbonate has been proposed to reduce the risk for contrast-induced nephropathy (CIN).
192. Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury.
作者: Christian Putensen.;Nils Theuerkauf.;Jörg Zinserling.;Hermann Wrigge.;Paolo Pelosi.
来源: Ann Intern Med. 2009年151卷8期566-76页
Trials have provided conflicting results regarding the effect of different ventilatory strategies on the outcomes of patients with the acute respiratory distress syndrome (ARDS) and acute lung injury.
193. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture.
作者: J Brent Richards.;Fotini K Kavvoura.;Fernando Rivadeneira.;Unnur Styrkársdóttir.;Karol Estrada.;Bjarni V Halldórsson.;Yi-Hsiang Hsu.;M Carola Zillikens.;Scott G Wilson.;Benjamin H Mullin.;Najaf Amin.;Yurii S Aulchenko.;L Adrienne Cupples.;Panagiotis Deloukas.;Serkalem Demissie.;Albert Hofman.;Augustine Kong.;David Karasik.;Joyce B van Meurs.;Ben A Oostra.;Huibert A P Pols.;Gunnar Sigurdsson.;Unnur Thorsteinsdottir.;Nicole Soranzo.;Frances M K Williams.;Yanhua Zhou.;Stuart H Ralston.;Gudmar Thorleifsson.;Cornelia M van Duijn.;Douglas P Kiel.;Kari Stefansson.;André G Uitterlinden.;John P A Ioannidis.;Tim D Spector.; .
来源: Ann Intern Med. 2009年151卷8期528-37页
Osteoporosis is a highly heritable trait. Many candidate genes have been proposed as being involved in regulating bone mineral density (BMD). Few of these findings have been replicated in independent studies.
194. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force.
作者: David I Buckley.;Rongwei Fu.;Michele Freeman.;Kevin Rogers.;Mark Helfand.
来源: Ann Intern Med. 2009年151卷7期483-95页
C-reactive protein (CRP) may help to refine global risk assessment for coronary heart disease (CHD), particularly among persons who are at intermediate risk on the basis of traditional risk factors alone.
195. Meta-analysis: retinal vessel caliber and risk for coronary heart disease.
作者: Kevin McGeechan.;Gerald Liew.;Petra Macaskill.;Les Irwig.;Ronald Klein.;Barbara E K Klein.;Jie Jin Wang.;Paul Mitchell.;Johannes R Vingerling.;Paulus T V M Dejong.;Jacqueline C M Witteman.;Monique M B Breteler.;Jonathan Shaw.;Paul Zimmet.;Tien Y Wong.
来源: Ann Intern Med. 2009年151卷6期404-13页
Retinal vessel caliber may be a novel marker of coronary heart disease (CHD) risk. However, the sex-specific effect, magnitude of association, and effect independent of traditional CHD disease risk factors remain unclear.
196. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?
作者: Lorenzo Fuccio.;Rocco Maurizio Zagari.;Leonardo Henry Eusebi.;Liboria Laterza.;Vincenzo Cennamo.;Liza Ceroni.;Diego Grilli.;Franco Bazzoli.
来源: Ann Intern Med. 2009年151卷2期121-8页
Helicobacter pylori infection is associated with gastric cancer, but the effect of eradication treatment on gastric cancer risk is not well defined.
197. Systematic review: glucose control and cardiovascular disease in type 2 diabetes.
作者: Tanika N Kelly.;Lydia A Bazzano.;Vivian A Fonseca.;Tina K Thethi.;Kristi Reynolds.;Jiang He.
来源: Ann Intern Med. 2009年151卷6期394-403页
Results from clinical trials examining the effect of intensive glucose control on cardiovascular disease have been conflicting.
198. Meta-analysis: travel and risk for venous thromboembolism.
The potential risk for travel-related venous thromboembolism (VTE) has become an important public health concern because of rapid increases in long-distance travel; however, previous studies on this relationship are surprisingly contradictory.
199. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.
作者: Finlay A McAlister.;Natasha Wiebe.;Justin A Ezekowitz.;Alexander A Leung.;Paul W Armstrong.
来源: Ann Intern Med. 2009年150卷11期784-94页
Guidelines recommend that patients with heart failure receive beta-blockers in doses used in the trials that have proven their efficacy. Although the adverse effects of beta-blockade are dose-related, it is unclear whether the benefits are.
200. Glycemic control in type 2 diabetes: time for an evidence-based about-face?
Some diabetes guidelines set low glycemic control goals for patients with type 2 diabetes mellitus (such as a hemoglobin A(1c) level as low as 6.5% to 7.0%) to avoid or delay complications. Our review and critique of recent large randomized trials in patients with type 2 diabetes suggest that tight glycemic control burdens patients with complex treatment programs, hypoglycemia, weight gain, and costs and offers uncertain benefits in return. We believe clinicians should prioritize supporting well-being and healthy lifestyles, preventive care, and cardiovascular risk reduction in these patients. Glycemic control efforts should individualize hemoglobin A(1c) targets so that those targets and the actions necessary to achieve them reflect patients' personal and clinical context and their informed values and preferences.
|